ArticleBlood2013

Phase 1 trial of IL-15 trans presentation blockade using humanized Mikβ1 mAb in patients with T-cell large granular lymphocytic leukemia.

Thomas A Waldmann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.